Source author record

Sarah Cherng

Sarah Cherng appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
3topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

Deep Representation Learning of Electronic Health Records to Unlock Patient Stratification at Scale

Deriving disease subtypes from electronic health records (EHRs) can guide next-generation personalized medicine. However, challenges in summarizing and representing patient data prevent widespread practice of scalable EHR-based stratification analysis. Here we present an unsupervised framework based on deep learning to process heterogeneous EHRs and derive patient representations that can efficiently and effectively enable patient stratification at scale. We considered EHRs of 1,608,741 patients from a diverse hospital cohort comprising of a total of 57,464 clinical concepts. We introduce a representation learning model based on word embeddings, convolutional neural networks, and autoencoders (i.e., ConvAE) to transform patient trajectories into low-dimensional latent vectors. We evaluated these representations as broadly enabling patient stratification by applying hierarchical clustering to different multi-disease and disease-specific patient cohorts. ConvAE significantly outperformed several baselines in a clustering task to identify patients with different complex conditions, with 2.61 entropy and 0.31 purity average scores. When applied to stratify patients within a certain condition, ConvAE led to various clinically relevant subtypes for different disorders, including type 2 diabetes, Parkinson's disease and Alzheimer's disease, largely related to comorbidities, disease progression, and symptom severity. With these results, we demonstrate that ConvAE can generate patient representations that lead to clinically meaningful insights. This scalable framework can help better understand varying etiologies in heterogeneous sub-populations and unlock patterns for EHR-based research in the realm of personalized medicine.

preprint2015arXiv

Forecasting and Uncertainty in Modeling the 2014-2015 Ebola Epidemic in West Africa

The Ebola epidemic in West Africa is the largest ever recorded, with over 27,000 cases and 11,000 deaths as of June 2015. The public health response was challenged by difficulties with disease surveillance, which impacted subsequent analysis and decision-making regarding optimal interventions. We developed a stage-structured model of Ebola virus disease (EVD). A key feature of the model is that it includes a generalized correction term accounting for factors such as the fraction of cases reported and fraction of the population at risk (e.g. due to contact patterns, interventions, spatiotemporal spread, pre-existing immunity, asymptomatic cases, etc.). We generated a range of short-term forecasts for Guinea, Liberia, and Sierra Leone, which we then validated using subsequent data. We also used the model to examine the uncertainty in the relative contributions to transmission by the different stages of infection (early, late, and funeral). We found that a wide range of forecasted trajectories fit approximately equally well to the early data. However, by including the correction factor term the best-fit models correctly forecasted EVD activity for all three countries, both individually and for all countries combined. In particular, the model correctly forecasted the slow-down in Liberia, as well as the continued exponential growth in Sierra Leone through November 2014. Parameter unidentifiability issues hindered estimation of the relative contributions of each stage of transmission from incidence and deaths data alone, which poses a challenge in determining optimal intervention strategies, and underscores the need for additional data collection. Even with these limited data, however, it is still possible to accurately capture and predict the epidemic dynamics by using a simplified correction term that approximately accounts for the complex underlying factors driving disease spread.